Anthony Fernandez (Refeyn Ltd.)

Fernandez, Anthony (Refeyn 202101–202301 CEO before Teledyne + Xennia Technology LEFT 1/23 for health reasons)

	Organisation	Refeyn Ltd.
	Group	Refeyn (Group)
	Product	mass photometry technology
	Product 2	mass photometer

Refeyn Ltd.. (1/25/21). "Press Release: Jonathan Flint, Chairman of the Board – Introducing Refeyn’s New CEO".

I’d like to share an important update with you to kick off the new year.

We’re pleased to announce that Refeyn recently appointed Anthony Fernandez as our new Chief Executive Officer (CEO). The appointment marks a new chapter in our story as we embark on an ambitious mission of growth in the coming years.

Anthony has had in-depth experience through the full product lifecycle within both, corporate and start-up environments, with a specific focus on commercializing disruptive and innovative technologies. His decades’ worth of leadership experience spans strategic marketing, sales and business development, and organisation scale-up across several verticals, including Aerospace & Defence, Healthcare, and Industry 4.0.

Most recently, Anthony served as the Vice President of Teledyne e2v Asia Pacific, based in Hong Kong, where he was responsible for driving regional strategy, identifying growth opportunities, expanding applications and manufacturing footprint, and enhancing local capabilities.

Prior to this, Anthony built his career with Xennia Technology, an industrial inkjet solutions start-up, where first, as a Software Engineer, he worked on image processing software and human-machine interfaces. Later, as a Product Manager, he helped commercialize novel printing platforms for the ceramics and textiles industries across Asia and Europe. This rapid export-based growth was recognized by The Queen’s Award for International Trade in 2010.

He holds a BSc (Hon’s) in Software Engineering from City, University of London and a Master’s in Business Administration from Imperial College Business School, London.

Of his new appointment, Anthony says, “Refeyn’s ground-breaking technology, thriving customer base, and exceptional people have put mass photometry at the forefront of bioanalytics innovation – I’m delighted to join the team and lead our next phase of growth and expansion.”

Jonathan Flint
Chairman of the Board
Refeyn Ltd.